Arbormed |
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-19843,ajax_fade,page_not_loaded,,select-theme-ver-4.2,wpb-js-composer js-comp-ver-5.4.4,vc_responsive
Novel Medicines

We acquire and advance proprietary drug candidates for underserved medical conditions with a focus on metabolic, pain/inflammation, and anti-aging therapeutic areas.

Complex Generics

These medicines generally have at least one feature that makes them harder to “genericize” under traditional approach. As a consequence, these drugs can face less competition. We acquire and commercialize complex generic medicines for the US market.

Cross-border, cross-cultural, multi-national with
capital efficient operations

Cross Border Network

Management team members has extensive networks with pharmaceutical and
biotech companies in North America, Europe and Asia.

Capital Efficient Operations

NRDO (No Research Development Only) portfolio management company
Novel Medicines – acquisition, preclinical/clinical development, licensing deal
Complex Generics – acquisition, regulatory, commercialization in the US market